Cancer Immunology, Immunotherapy (Dec 2024)
Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study
- Emiel A. De Jaeghere,
- Sandra Tuyaerts,
- An M. T. Van Nufel,
- Ann Belmans,
- Kris Bogaerts,
- Regina Baiden-Amissah,
- Lien Lippens,
- Peter Vuylsteke,
- Stéphanie Henry,
- Xuan Bich Trinh,
- Peter A. van Dam,
- Sandrine Aspeslagh,
- Alex De Caluwé,
- Eline Naert,
- Diether Lambrechts,
- An Hendrix,
- Olivier De Wever,
- Koen K. Van de Vijver,
- Frédéric Amant,
- Katrien Vandecasteele,
- Hannelore G. Denys
Affiliations
- Emiel A. De Jaeghere
- Department of Medical Oncology (Route 535), Ghent University Hospital
- Sandra Tuyaerts
- Gynaecologic Oncology, Department of Oncology, KU Leuven
- An M. T. Van Nufel
- Anticancer Fund (ACF)
- Ann Belmans
- Biostatistics and Statistical Bioinformatics Centre (L-BioStat), KU Leuven
- Kris Bogaerts
- Biostatistics and Statistical Bioinformatics Centre (L-BioStat), KU Leuven
- Regina Baiden-Amissah
- Gynaecologic Oncology, Department of Oncology, KU Leuven
- Lien Lippens
- Cancer Research Institute Ghent (CRIG)
- Peter Vuylsteke
- Department of Hemato-Oncology, Centre Hospitalier Universitaire Université Catholique de Louvain Namur (Sainte-Elisabeth)
- Stéphanie Henry
- Department of Hemato-Oncology, Centre Hospitalier Universitaire Université Catholique de Louvain Namur (Sainte-Elisabeth)
- Xuan Bich Trinh
- Department of Gynecologic Oncology and Senology, University Hospital Antwerp
- Peter A. van Dam
- Department of Gynecologic Oncology and Senology, University Hospital Antwerp
- Sandrine Aspeslagh
- Department of Medical Oncology, University Hospital Brussels
- Alex De Caluwé
- Department of Radiation Oncology, Jules Bordet Institute
- Eline Naert
- Department of Medical Oncology (Route 535), Ghent University Hospital
- Diether Lambrechts
- VIB–KU Louvain Center for Cancer Biology
- An Hendrix
- Cancer Research Institute Ghent (CRIG)
- Olivier De Wever
- Cancer Research Institute Ghent (CRIG)
- Koen K. Van de Vijver
- Cancer Research Institute Ghent (CRIG)
- Frédéric Amant
- Gynaecologic Oncology, Department of Oncology, KU Leuven
- Katrien Vandecasteele
- Cancer Research Institute Ghent (CRIG)
- Hannelore G. Denys
- Department of Medical Oncology (Route 535), Ghent University Hospital
- DOI
- https://doi.org/10.1007/s00262-024-03873-5
- Journal volume & issue
-
Vol. 74,
no. 1
pp. 1 – 4
Abstract
No abstracts available.
